Korben Park - Border Collies (ANKC Registered)

Health Tests

Core Tests(2/3)

View breed core tests

Korben Park - Border Collies (ANKC Registered) conducts 2 out of 3 core health tests which RightPaw believe are most important to conduct for the Border Collie.

CEA

Genetic Test

Collie Eye Anomaly (CEA), also known as ‘Choroidal Hypoplasia’ (CH), is a genetic disease… Read more

PLL

Genetic Test

Primary Lens Luxation (PLL) is a genetic cause of blindness found in dogs, particularly affecting… Read more

Korben Park - Border Collies (ANKC Registered) conducts 11 additional tests available for the Border Collie.

Cubilin Deficiency

Genetic Test

This a genetic cause of cobalamin malabsorption found in Border Collies. Affected dogs cannot absorb Vitamin B12 (cobalamin) from the gut and therefore experience a range of gastrointestinal disease. There is a DNA test available to identify whether a breeding dog is carrying this condition.

Cystinuria

Genetic Test

This condition mainly affects Newfoundlands although other breeds can be affected. It is a genetic condition which results in the production of kidney and bladder stones. There is a DNA test available to confirm that breeding dogs are not carrying this condition.

Degenerative Myelopathy (DM)

Genetic Test

This is a disease affecting the spinal cord of older dogs, initially causing wobbliness and eventually hindlimb paralysis. It can affect a wide range of breeds. There is now a DNA test that can indicated if a breeding dog is carrying this disease.

Goniodysgenesis

Genetic Test

Goniodysgenesis is a genetic cause of ‘glaucoma’, or increased pressure in the eye. Untreated glaucoma can result in eye pain and blindness. There is a DNA test available to identify whether a breeding dog is carrying this genetic cause of glaucoma.

MDR1

Genetic Test

The MDR-1 gene (Multi-drug Resistance Gene 1) is responsible for producing proteins that protect the brain from harmful chemicals. Some breeds have a mutation in this gene resulting in them being dangerously sensitive to certain chemicals and drugs. It is recommended to test these breeding dogs for the MDR-1 mutation, so they do not pass on the sensitivity to their puppies.

Myotonia Hereditaria

Genetic Test

Myotonia Hereditaria/Congenita is a genetic disease that causes muscle problems resulting in a stiff gait and difficulty swallowing. There is a DNA test available to identify whether a breeding dog might be carrying this condition.

NCL

Genetic Test

Neuronal Ceroid Lipofuscinosis (NCL) is a neurodegenerative disorder found in many breeds of dog. 7 varieties have been identified so far, affecting different breeds. There are DNA tests for each type, to identify whether a breeding dog might be carrying this condition.

Raine Syndrome

Genetic Test

Raine Syndrome, or Canine Dental Hypomineralisation, is a genetic disorder found in Border Collies, that causes their teeth to wear down abnormally fast. There is a DNA test available to identify whether a breeding dog is carrying this condition.

Sensory Neuropathy

Genetic Test

Sensory Neuropathy is a serious genetic disease causing progressive neurological degeneration. Affected dogs develop difficulty with basic activities such as walking and swallowing and will eventually require euthanasia. There is a DNA test available to identify if a breeding dog is carrying this disease.

TNS

Genetic Test

Trapped Neutrophil Syndrome (TNS) is a genetic disease affecting Border Collies. It results in the dog’s white blood cells not being released from the bone marrow properly, meaning they cannot fight off infections. There is a DNA test available to identify whether a breeding dog is carrying this condition.

VWD-2

Genetic Test

Von Willebrand’s Disease (VWD/vWD) is a genetic bleeding disorder caused by a lack of a specific clotting factor. There are three forms of the disease, types 1, 2 & 3. A DNA test is available for each type of VWD to identify whether a breeding dog is a carrier or might be affected. The severity of VWD varies widely between breeds and individuals, ranging from life threatening, through to having no impact on clotting ability.